These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36510470)

  • 1. Corruption in healthcare: a view from the pandemic.
    Duliba Y; Streltsov Y; Kharchenko V; Korchak N; Antonova O
    Med Leg J; 2024 Mar; 92(1):43-45. PubMed ID: 36510470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review.
    Griffore KA; Bowra A; Guilcher SJT; Kohler J
    Global Health; 2023 Nov; 19(1):91. PubMed ID: 38001483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corruption, public trust and medical autonomy in the public health sector of Montenegro: Taking stock of the COVID-19 influence.
    Radević I; Alfirević N; Lojpur A
    PLoS One; 2022; 17(9):e0274318. PubMed ID: 36074759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing health corruption during a public health crisis through anticipatory governance: Lessons from the COVID-19 pandemic.
    Gonzalez-Aquines A; Kowalska-Bobko I
    Front Public Health; 2022; 10():952979. PubMed ID: 35968489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations.
    Gorodensky A; Bowra A; Saeed G; Kohler J
    BMJ Open; 2022 Dec; 12(12):e064137. PubMed ID: 36549737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fraud within the Nigerian health system, a double threat for resilience of a health system and the response to the COVID-19 pandemic: a review.
    Akokuwebe ME; Idemudia ES
    Pan Afr Med J; 2023; 45():116. PubMed ID: 37745915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covid-19 corruption in the public health sector-emerging evidence from Bangladesh.
    Hossain MM; Rahaman MM; Rahman MJ
    Health Policy Plan; 2023 Aug; 38(7):799-821. PubMed ID: 37243741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recalibrating the anti-corruption, transparency, and accountability formula to advance public health.
    Wierzynska A; Steingrüber S; Oroxom R; Bauhoff S
    Glob Health Action; 2020; 13(sup1):1701327. PubMed ID: 32194013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corruption in Anglophone West Africa health systems: a systematic review of its different variants and the factors that sustain them.
    Onwujekwe O; Agwu P; Orjiakor C; McKee M; Hutchinson E; Mbachu C; Odii A; Ogbozor P; Obi U; Ichoku H; Balabanova D
    Health Policy Plan; 2019 Sep; 34(7):529-543. PubMed ID: 31377775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the link between healthcare expenditure, corruption, and COVID-19 mortality.
    Squalli J
    Sci Rep; 2024 Jun; 14(1):12702. PubMed ID: 38830982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences of corruption types in selected Western and central-eastern health systems during the COVID-19 pandemic: a rapid review.
    Gonzalez-Aquines A; Cordero-Perez AC; Kowalska-Bobko I
    Front Public Health; 2023; 11():1269189. PubMed ID: 37876721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CENTRALIZATION AND CORRUPTION IN HEALTH PROCUREMENT OF THE SOUTHERN EUROPEAN UNION COUNTRIES.
    Geropoulos N; Voultsos P; Geropoulos M; Tsolaki F; Tagarakis G
    Georgian Med News; 2024 Mar; (348):10-21. PubMed ID: 38807383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploration of anti-corruption and health in international organizations.
    Bowra A; Saeed G; Gorodensky A; Kohler JC
    PLoS One; 2022; 17(8):e0269203. PubMed ID: 35917329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [STATE PROCUREMENTS: STUDYING THE IMPLEMENTATION OF NATIONAL POLICIES IN TERMS OF PANDEMIC COVID-19].
    Ustymenko V; Soshnykov A; Tokarska A; Makarenko O; Nesterenko K
    Georgian Med News; 2021 Mar; (312):157-163. PubMed ID: 33964845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the COVID-19 pandemic to corrupt practices: a tale of two evils.
    Usman M; Husnain M; Akhtar MW; Ali Y; Riaz A; Riaz A
    Environ Sci Pollut Res Int; 2022 Apr; 29(20):30297-30310. PubMed ID: 35000178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-corruption, Transparency and Accountability: Case Study of Healthcare in the Arab Countries.
    Hunter M; Uwaydah Mardini R; El-Seblani A; Elsayed S
    Glob Health Action; 2020; 13(sup1):1704529. PubMed ID: 32194015
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploring corruption in the South African health sector.
    Rispel LC; de Jager P; Fonn S
    Health Policy Plan; 2016 Mar; 31(2):239-49. PubMed ID: 26104821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. We Need to Talk About Corruption in Health Systems.
    Hutchinson E; Balabanova D; McKee M
    Int J Health Policy Manag; 2019 Apr; 8(4):191-194. PubMed ID: 31050963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-sectoral collaborations in selected countries of the Eastern Mediterranean region: assessment, enablers and missed opportunities from the COVID-19 pandemic response.
    El-Jardali F; Fadlallah R; Daher N
    Health Res Policy Syst; 2024 Jan; 22(1):14. PubMed ID: 38267995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.